links directory uk  
 
 

UK Links Directory


Arts
:: Crafts
:: Art History
:: Bodyart

Business
:: Human Resources
:: Investing
:: Issues

Computing
:: Graphic Design
:: Hardware
:: Internet

Shopping
:: Antiques and Collectibles
:: Auctions
:: Autos

Health
:: Addictions
:: Aging
:: Alternative

Towns and Cities
:: England
:: Wales
:: Scotland

Contact us

Mortgages london

I am not a plastic bag


©200

privacy

 

 

Biotechnology and Pharmaceuticals - uk directory



Biotechnology and Pharmaceuticals

ADD YOUR SITE

Fumair Ltd : Manufacturers of high quality laboratory fume cupboards, fume extraction systems and associated equipment.
Sci7 : Biotechnology Information Technology
Spectrum Pharmaceuticals to Present at the BIO CEO Investor Conference
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company?s business strategy will be given at the BIO CEO Investor Conference, being held at the Waldorf=Astoria Hotel in New York City.
NovaBay Pharmaceuticals to Hold Conference Call to Provide Year-End Business Update and 2012 Outlook
EMERYVILLE, Calif. -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide(R) compounds for the topical treatment ...
Biotechnology (Pharmaceuticals) (Global)
NEW YORK, Jan. 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Biotechnology (Pharmaceuticals) (Global) http://www.reportlinker.com/p0763578/Biotechnology-Pharmaceuticals-Global.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical ...
Synta Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
Synta Pharmaceuticals Corp. today announced that the Company will be presenting at the 2012 Biotechnology Industry Organization CEO & Investor Conference on Mond
Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
THE WOODLANDS, Texas, Feb. 7, 2012 /PRNewswire/ --  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX - News)  announced today that Arthur T. Sands, M.D., Ph.D. , Lexicon's president and chief executive officer, will ...


Writen by: